Top Market Shifts Transforming the Knee Bursitis Market Landscape: Key Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Knee Bursitis Market Through 2025?
The market for knee bursitis has experienced significant expansion lately, projecting an increase from its 2024 valuation of $2.66 billion to $2.86 billion by 2025, reflecting a robust compound annual growth rate of 7.3%. This upward trajectory during the past period stems from several contributing factors, including an increasing elderly demographic, greater engagement in athletic pursuits and physical exercises, advancements in methods used for diagnosis, enhancements in the availability of medical care, and educational initiatives targeting both medical practitioners and the general public.

What's the Projected Size of the Global Knee Bursitis Market by 2029?
The knee bursitis market size is projected to witness significant growth in the coming years. It is expected to reach $3.72 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The forecast period growth can be attributed to rising awareness campaigns for prevention and management, higher disposable incomes, growing healare expenditure, and increased diagnosis and awareness of knee bursitis. Key trends anticipated during this period include advancements in diagnostic technologies, development of innovative therapies, progress in research and development efforts, and the adoption of telemedicine and remote monitoring solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Top Growth Drivers in the Knee Bursitis Industry: What's Accelerating the Market?
The rising incidence of bone-related diseases is anticipated to drive the growth of the knee bursitis market in the coming years. Bone-related diseases include conditions such as osteoporosis, arthritis, and bone cancer, which impact the strength, structure, and overall function of the skeletal system. Factors such as aging populations, sedentary habits, inadequate nutrition, and environmental influences contribute to the growing prevalence of these conditions. Diseases like osteoarthritis and rheumatoid arthritis can trigger knee bursitis by causing inflammation and excessive pressure on the knee bursa, leading to pain, swelling, and limited joint mobility. For example, in September 2022, Healthy Bones Australia, a non-profit organization based in Australia, reported that around 6.2 million Australians aged 50 and above were estimated to have osteoporosis or osteopenia in 2022, with 22% affected by osteoporosis and 78% by osteopenia among the 4.74 million with poor bone health. Hence, the increasing prevalence of bone-related diseases is fueling the growth of the knee bursitis market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

What Are the Main Segments in the Knee Bursitis Market?
The knee bursitismarket covered in this report is segmented -

1) By Diagnosis: Imaging Test; Other Diagnosis Tests
2) By Treatment: Medication; Therapy; Surgery; Other Treatments
3) By End User: Hospitals And Clinics; Diagnostic Centers; Research Centers; Academic Institutes; Other End Users

Subsegments:
1) By Imaging Test: X-Ray; MRI (Magnetic Resonance Imaging); Ultrasound
2) By Other Diagnosis Tests: Physical Examination; Aspiration Of Joint Fluid; Blood Tests

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16460&type=smp

Which Top Companies are Driving Growth in the Knee Bursitis Market?
Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

Which Regions Will Dominate the Knee Bursitis Market Through 2029?
North America was the largest region in the knee bursitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16460

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.